Multiple Assemblies exist for SMTL entry 3f3v
Kinase domain of cSrc in complex with inhibitor RL45 (Type II); X-RAY DIFFRACTION 2.60 Å

SMTL ID
3f3v.1
Ligands
1-{4-[(6-AMINOQUINAZOLIN-4-YL)AMINO]PHENYL}-3-[3-TERT-BUTYL-1-(3-METHYLPHENYL)-1H-PYRAZOL-5-YL]UREA
Polypeptides
Proto-oncogene tyrosine-protein kinase Src
Oligo-state
monomer
SMTL ID
3f3v.2
Ligands
1-{4-[(6-AMINOQUINAZOLIN-4-YL)AMINO]PHENYL}-3-[3-TERT-BUTYL-1-(3-METHYLPHENYL)-1H-PYRAZOL-5-YL]UREA
Polypeptides
Proto-oncogene tyrosine-protein kinase Src
Oligo-state
monomer